| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/15/2004 | CN1529606A Preparation containing seleniter or selenate for treating wound |
| 09/15/2004 | CN1529604A Drug for treatment of osteonecrosis and for management of patients at risk of evelopment osteonecrosis |
| 09/15/2004 | CN1529603A Use of bile acid or bile salt fatty acid conjugates |
| 09/15/2004 | CN1529601A 四氢喹啉衍生物 Tetrahydroquinoline derivative |
| 09/15/2004 | CN1529600A Use of NK-1-receptor antagonists tomodify unwanted behavior indogs, casts and horses |
| 09/15/2004 | CN1529599A Acylic piperazine and piperidine derivatives which are used for treating neuronal damage |
| 09/15/2004 | CN1529597A Imidazo (1,2-A)_pyridine derivatives as mGLUR5 antagonists |
| 09/15/2004 | CN1529595A 4,5-hydro-1H-pyrazole derivative having protent CB1-antagonistic |
| 09/15/2004 | CN1529594A Injectable galenic formulation for use in diagnosis or photodynamic therapy and method for preparing same |
| 09/15/2004 | CN1529590A Compositions and methods to treat neovascularization and disease associated with thereof |
| 09/15/2004 | CN1529587A Medicine bisacodyl granular composition comprising dung softening poloxamer and coated with enteric-coatel casing |
| 09/15/2004 | CN1529578A Use of gourd oil for inhibiting s alpha-reductase activity |
| 09/15/2004 | CN1528746A Intermediate for preparing compounds having serotonin-2 receptor antagonistic and alpha-1 blocking action and its preparing method |
| 09/15/2004 | CN1528742A Compound for treating asthma, irritability an a inflammation and its intermediate |
| 09/15/2004 | CN1528434A Chinese medicine composition for treating myopia and preparing method thereof |
| 09/15/2004 | CN1528393A Medicine for treating goiter |
| 09/15/2004 | CN1528382A Medicine for preventing and treating chronic exhaustion syndrome and preparing method thereof |
| 09/15/2004 | CN1528381A Medicine for preventing and treating chronic exhaustion syndrome and preparing mthod thereof |
| 09/15/2004 | CN1528380A Medicine for preventing and treating chronic exhaustion syndrome and preparing method thereof |
| 09/15/2004 | CN1528373A Antifatigue beverage |
| 09/15/2004 | CN1528357A Use of plant spearmint for preparing medicine for treating esophagus cancer |
| 09/15/2004 | CN1528349A Health-care medicinal composition, and preparing method and use thereof |
| 09/15/2004 | CN1528334A Use of anthracene-ring derivatives for preparing medicine to treat brain tumor |
| 09/15/2004 | CN1166690C Hepatitis C inhibitor peptides |
| 09/15/2004 | CN1166683C New BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 09/15/2004 | CN1166678C Purine derivatives |
| 09/15/2004 | CN1166677C Thiophene A2A receptor aganoists |
| 09/15/2004 | CN1166667C Imidazoimidazoles and trizoles as anti-inflammatory agents |
| 09/15/2004 | CN1166666C Fused imiazole compounds and remedies for diabetes mellitus |
| 09/15/2004 | CN1166658C 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors |
| 09/15/2004 | CN1166654C Benzoylguanidine derivatives wit advantageous properties, method for producing them and their use in production of medicaments |
| 09/15/2004 | CN1166643C 4-phenyl-pyrimidine derivatives |
| 09/15/2004 | CN1166638C Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same |
| 09/15/2004 | CN1166633C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them |
| 09/15/2004 | CN1166632C New hydroxamic acid compounds, their preparation method and medicine composition containing them |
| 09/15/2004 | CN1166629C Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same |
| 09/15/2004 | CN1166618C New selective retinoid agonists |
| 09/15/2004 | CN1166408C Substrate tablet containing trimetzidine capable of long time controlled release after oral application |
| 09/15/2004 | CN1166403C Multicatalytic protease inhibitors |
| 09/15/2004 | CN1166402C Composite Chinese medicine with health care function |
| 09/15/2004 | CN1166386C 'Yizhi' capsule for intelligency |
| 09/15/2004 | CN1166365C Alendronic-acid medicind composition and use of same for preparing medictne for inhibiting bone resorption of humanbody |
| 09/15/2004 | CN1166361C Use of CGRP antagonists and CGRP release inhibitors for controlling menopausal hot flashes |
| 09/14/2004 | US6790992 Scyphostatin analogues as SMase inhibitors |
| 09/14/2004 | US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury |
| 09/14/2004 | US6790984 Process for purifying pravastatin sodium from a fermentation broth |
| 09/14/2004 | US6790979 Use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in subject with androgen-related affliction |
| 09/14/2004 | US6790963 E-isomeric fullerene derivatives |
| 09/14/2004 | US6790953 Ether compounds |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790938 Human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins |
| 09/14/2004 | US6790864 Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group |
| 09/14/2004 | US6790860 Pyrrolidine derivatives |
| 09/14/2004 | US6790854 Diphenylalkylamine derivatives useful as opioid receptor agonists |
| 09/14/2004 | US6790852 Heterocyclic nitrogen compounds such as 2-(2,6-dichlorophenyl) -4-(3-bromophenyl)-5-(2-(3- hydroxypropylamino)pyrimidin-4-yl) -n-h-imidazole, used as tyrosine kinase inhibitors; anticarcinogenic or antitumor agents |
| 09/14/2004 | US6790848 4-piperazinylindole derivatives with 5-HT6 receptor affinity |
| 09/14/2004 | US6790836 Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
| 09/14/2004 | US6790832 Antithrombin; antiinflammatory agents, rheumatic diseases |
| 09/14/2004 | US6790826 Human haemopoietic maturation factor |
| 09/14/2004 | US6790825 Stimulating secretion of pancreatic juices |
| 09/14/2004 | US6790824 Cytokines having neurotrophic activity |
| 09/14/2004 | US6790639 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/14/2004 | US6790637 Mammalian gene, BCL-W, belongs to the BCL-2 family of apoptosis-controlling genes |
| 09/14/2004 | US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions |
| 09/14/2004 | US6790626 Comprises preference for pyrimidine nucleotides (uridine triphosphate) over purine nucleotides; for determining ligand binding, detecting expression, drug screening, treatment |
| 09/14/2004 | US6790439 Thrombopoietin compositions |
| 09/14/2004 | US6790434 Sunscreen agents; mixture of deactivated bacteria and plant extract |
| 09/14/2004 | CA2315826C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 09/14/2004 | CA2280708C Cetp activity inhibitors |
| 09/14/2004 | CA2264549C Spirocyclic dopamine receptor subtype ligands |
| 09/10/2004 | WO2004077367A1 Tetracyclic sulfenamide compound |
| 09/10/2004 | WO2004076667A1 Double-strand rna oligonucleotide having effect of inhibiting the expression of cyclin b gene |
| 09/10/2004 | WO2004076478A1 PEPTIDE DERIVATIVES HAVING β-SECRETASE INHIBITORY ACTIVITY |
| 09/10/2004 | WO2004076463A1 Inhibitors |
| 09/10/2004 | WO2004076458A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | WO2004076446A1 Benzothiophene derivative |
| 09/10/2004 | WO2004076441A1 Process for producing acid adduct salt of polyacidic base compound |
| 09/10/2004 | WO2004076420A1 Heteroarylcarbamoylbenzene derivative |
| 09/10/2004 | WO2004076349A1 Therapeutic malonic acid/acetic acid c60 tri-adducts of buckminsterfullerene and methods related thereto |
| 09/10/2004 | WO2004075924A1 Gene transfer promoter and gene tansfer composition containing the same |
| 09/10/2004 | WO2004075920A1 Sustained-release pharmaceutical composition for lung administration |
| 09/10/2004 | WO2004075917A1 Organ or tissue fibrosis inhibitor |
| 09/10/2004 | WO2004075906A1 Antiinflammtory agent and antiinflammatory medical material |
| 09/10/2004 | WO2004075905A1 Muscle-building agent and preventive or remedy for muscle weakening |
| 09/10/2004 | WO2004075890A1 Medicinal composition containing stabilized imidazole derivative and method of stabilizing imidazole derivative |
| 09/10/2004 | WO2004065626A3 A method of sepsis prognosis |
| 09/10/2004 | WO2004056755A3 Compounds for the inhibition of non-proteolytic enzymes |
| 09/10/2004 | WO2004054565A8 Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 09/10/2004 | WO2004022128A3 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 09/10/2004 | WO2004017920B1 Novel biphenyl and biphenyl-like cannabinoids |
| 09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
| 09/10/2004 | WO2004007444A3 N-hydroxyamide derivatives possessing antibacterial activity |
| 09/10/2004 | WO2003106970A3 P27 prevents cellular migration |
| 09/10/2004 | WO2003090671A3 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| 09/10/2004 | WO2003087092A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease |
| 09/10/2004 | WO2003079984A3 Substituted tetracycline compounds |
| 09/10/2004 | WO2003070897A3 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/10/2004 | WO2003061652A8 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |